Transplantation of multiple abdominal viscera. by Starzl, TE et al.
Original Contributions 
Transplantation of Multiple 
Abdominal Viscera 
qh~mas E. Starzl, MD, PhD; Marc I. Rowe, MD; Satoru Todo, MD; Ronald Jaffe, MS, SCh; 
Andreas Tzakis, MD; Allen L. Hoffman, MD; Carlos Esquivel, MD, PhD; Kendrick A. Porter, MD, DSc; 
Raman Venkataramanan, PhD; Leonard Makowka, MD, PhD; Rene Duquesnoy, PhD 
Two children with the short-gut syndrome and secondary liver failure were 
treated with evisceration and transplantation en bloc of the stomach, small 
intestine, colon, pancreas, and liver. The first patient died perioperatively, but 
the second lived for more than 6 months before dying of an Epstein-Barr 
virus-associated Iymphoproliferative disorder that caused biliary obstruction 
and lethal sepsis. There was never evidence of graft rejection or of graft-vs-host 
disease in the long-surviving child. The constituent organs of the homograft 
functioned and maintained their morphological integrity throughout the 193 
days of survival. 
IN OLDER investigations, maximum 
survival after multivisceral transplan-
tation in untreated dogs was 9 days. 1,2 
The liver as part of the multivisceral 
graft was rejected later and less severe-
ly than after liver transplantation alone. 
In addition, histopathologic findings 
suggestive of graft-vs-host disease 
(GVHD) were widespread by the time 
of death. 2 
See also pp 1397, 1458 and 1483. 
We have attempted the same opera-
tion in two children, one of whom sur-
vived for more than 6 months before 
dying of complications from the Iympho-
proliferative disease (LPD) that is asso-
ciated with Epstein-Barr virus infec-
tions. 3" Two other patients are known to 
have had similar procedures. ' 
METHODS 
Technique Standardization in Pigs 
Outbred Landrace pigs weighing 15 
to 25 kg were anesthetized with pento-
barbital sodium and ketamine hydro-
chloride and submitted to the same op-
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eration as shown in Fig 1 except that the 
retrohepatic inferior vena cava was re-
placed with the same segment from the 
donor. The donor organs were chilled 
with intra-aortic lactated Ringer's so-
lution. Graft splenectomy, cyclosporine 
therapy (given orally or by a brief intra-
venous course), and oral prednisone did 
not have a predictable effect on the sur-
vival of the 22 pigs that lived through 
operation and for at least 2 days (Table 
1). Diarrhea was a frequent problem. 
Eight animals developed skin lesions of 
GVHD (Fig 2). Sepsis or GVHD usually 
was suspected even when the cause of 
death was not obvious with gross exami-
nation at autopsy. Intestinal perfora-
tion, probably secondary to rejection, 
was found in 5 pigs. One animal that was 
treated with a short course of cyclospor-
ine lived for 104 days, had seemingly 
normal stools, and ate well enough to 
gain weight from 12.5 to 30 kg. Biopsy 
specimens of the jejunum, spleen, and 
liver obtained 2 months after operation 
were normal. At autopsy, there was no 
grossly identifiable cause of death al-
though the clinical suspicion was of 
GVHD. 
Case Reports 
CASE I.-A 6JOh2-year-old white girl 
lost most of her small bowel, necessitat-
ing total parenteral hyperalimentation 
(TPN), after it had been sucked out 
while she was sitting on the drain of a 
swimming pool that was being emptied. 
During the following year, she devel-
oped liver failure and underwent multi-
ple surgical procedures , including a cen-
tral splenorenal shunt. She was 
admitted to the Children's Hospital of 
Pittsburgh on July 29, 1983, with heart 
failure, pulmonary edema, bilateral 
pleural effusions, anasarca, renal fail-
ure, and liver failure. Total serum bili-
rubin level was 503 )J.mol/L; prothrom-
bin time, 21 seconds (control, 12 
seconds); and serum albumin level, 19 
giL. By August 17, 1983, when a donor 
became available, she was anuric and 
receiving ventilatory assistance al-
though still conscious. 
The 27-month-old male donor had the 
same blood type as the recipient (A, 
Rh+). The graft was core-cooled with 
chilled intra-aortic lactated Ringer's so-
lution and removed in an adjacent oper-
ating room. The cold ischemia time was 
1 hour. There was no warm ischemia. 
The organs transplanted were the same 
as in Fig 1 except that the kidneys were 
also included with the multi visceral 
graft and connected to the recipient 
bladder with ureteroneocystostomies. 
Exsanguinating hemorrhage was con-
tinuous throughout the recipient opera-
tion, requiring transfusion of 61 750 mL 
of blood. When the graft was revascu-
larized, it had a normal appearance but 
two episodes of cardiac arrest occurred 
several minutes later, followed by in-
tractable hypotension that continued 
until death of the patient 30 minutes 
after arrival in the intensive care unit. 
CASE 2.-A 3112-year-old black girl 
underwent multi visceral transplanta-
tion at Children's Hospital of Pitts-
burgh on November 1, 1987. Her dis-
ease began with perinatal volvulus and 
gangrene for which massive small-bow-
el resection was required with jejunoi-
leal anastomosis. Liver failure second-
ary to TPN was progressive from the 
age of2 years. By the time oftransplan-
tation, the child weighed 14 kg (50th 
percentile) and was 82 cm tall (fifth per-
centile). She had hepatosplenomegaly 
and scars from mUltiple abdominal pro-
cedures. Total bilirubin level was 470 
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Fig 1. - The recipient operation of multivisceral transplantation. Note that the venous outflow of the graft was 
into a cloaca of the left and middle hepatic veins, leaving the recipient inferior vena cava intact. A indicates 
donor aorta; HA, hepatic artery; SA, splenic artery; LGA, left gastric artery; SMA, superior mesenteric artery; 
IMA, inferior mesenteric artery; and GDA, gastro-duodenal artery. 
~mofgi; prothrombin time, 18.2 sec-
onds; serum albumin level, 20 giL; and 
aspartate aminotransferase level, 303 
UIL. Serum urea nitrogen, creatinine, 
and serum electrolyte levels were nor-
mal. The hematocrit was 0.38; white 
blood cell count, 3800 x 1O'1L; and plate-
lets, 90000 x 1O'1L. There was radiolog-
ical evidence of pulmonary edema. 
The Donor Operation 
The donor for patient 2 was a 2-
month-old white female weighing 3.25 
kg who had a closed-head injury 4 days 
previously. Results of blood chemistry 
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studies were normal except for an eleva-
tion of total bilirubin level to 41 ~molgi 
on the final day. Ten milligrams of 
OKT3, a mouse anti-human T-Iympho-
cyte monoclonal antibody: was given 
intravenously 90 minutes before remov-
ing the graft. The graft was cooled with-
out preliminary warm ischemia by in-
fusing 500 mL of the special cold 
preservation fluid recently developed at 
the University of Wisconsin.7" It was 
stored in an ice chest and revascularized 
in the recipient after 6 hours 38 minutes 
of cold ischemia. The spleen was re-
moved immediately. 
The Recipient 
Operation. - Patient 2 had removal 
of the liver, pancreas, spleen, distal part 
of the stomach, duodenum, residual 
small intestine, and ascending, trans-
verse, and descending colon. The distal 
sigmoid colon and rectum as well as a 
cuff of proximal stomach were retained. 
The recipient retrohepatic inferior vena 
cava was kept intact, and a cloaca was 
fashioned from the left and middle he-
patic veins to which the suprahepatic 
inferior vena cava of the multi visceral 
graft was anastomosed for venous out-
flow (Fig 1). The donor inferior vena 
cava was ligated below the liver. The 
distal graft aorta was anastomosed to 
the midabdominal aorta of the recipient 
(Fig 1). Revascularization did not cause 
cardiovascular instability or bleeding; 
most of the total operative blood loss of 
5050 mL occurred during donor organ 
removal. 
Gastrogastrostomy was performed, 
as well as Heineke-Mikulicz pyloro-
plasty of the graft, to facilitate gastric 
emptying (Fig 1). Colocolostomy was 
performed. Five days later, the patient 
was reexplored and pinhole perfora-
tions were found at both the upper and 
lower anastomoses. The gastrogastros-
tomy was reinforced and left intact. Dis-
tally, the colonic anastomosis was con-
verted to an end sigmoid colostomy with 
suture closure of the native colon rem-
nant (Fig 1). 
Postoperative Fluid. Electrolyte, 
and Nutritional Management.-
Right-sided filling pressures and serial 
monitoring of urinary output and con-
centrations guided intravenous therapy 
with crystalloid and colloid in the acute 
postoperative setting. Thtal parenteral 
nutrition was used until the gastrointes-
tinal tract regained function. As enteral 
feeds were increased, the volume of 
TPN was reduced accordingly (Fig 3). 
The child could not be taught the physi-
cal act of eating. 
Enteral feedings were started 2 
weeks after operation through a trans-
nasal jejunostomy tube. Conversion to a 
nasogastric feeding tube was possible 
by the fifth week when gastric emptying 
had improved. Initially, feedings were 
continuous. As gastrointestinal tract 
function improved, intermittent feed-
ings were tolerated , and by day 135, 
intermittent intake was used exclu-
sively. 
In the early postoperative period, en-
teral feedings were with simple solu-
tions such as 5% glucose in an isotonic 
electrolyte solution (Pedialyte) and an 
iso-osmolar concentration of an elemen-
tal diet (Vivonex). More complex for-
mulas (Portagen, Pregestimil) were not 
well tolerated. The most effective for-
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Table 1. - Fate of 22 (of 34) Pigs That Survived for at Least 2 Days After Operation 
Group No. of Pigs Survival, No. of Days 
1 No treatment 6 5, 14, 9, 12, 10, 7 
2 Oral cyclosporine, 20 mglKg, and prednisone, 5 mg/d 6 104,2,23, 16,9,9 
3 Same as group 2; graft splenectomy 5 23, 18, 7, 11, 2 
4 Same as group 3; 6 mglKg of cyclosporine intravenously, days 1-3 5 14,17,3,15,14 
Fig 2. -Skin biopsy from a pig 14 days after multivisceraltransplantation. Note the lymphocytic infiltrate at the 
dermal-epidermal junction and lymphocytes in proximity to necrotic epithelial cells (satellitosis) (hematoxylin-
eosin, x 350). 
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Fig 3. - Enteral and parenteral alimentation. As a blenderized diet was increased, we were able to gradually 
reduce total parental hyperalimentation (TPN) to a very low level. 
mula appeared to be an iso-osmolar ele-
mental diet (Peptamen) containing pep-
tides as the protein source and only a 
small amount of long-chain triglycer-
ides, which allowed TPN to be gradually 
reduced. Shortly thereafter, it was pos-
sible to give a blenderized diet contain-
ing Peptamen, meats, and vegetables 
and to progressively wean her from 
TPN (Fig 3). Bulk fiber in the fonn of 
pectin or psyllium complexes and the 
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bile-salt binding agent, cholestyramine, 
were added at various times to slow the 
transit time and improve fluid ab-
sorption. 
Qualitative and quantitative mea-
surements of intravenous and enteral 
infusates as well as output of urine, 
stool, and catheter drainage (gastric, 
biliary, and Jackson-Pratt) were done. 
Daily weights were taken. These data 
were used to guide volume replace-
ment, electrolyte management, and 
nutrition. 
Infectious Disease 
Broad-spectrum antibiotic coverage 
for patient 2 was provided perioper-
atively with intravenous ampicillin sodi-
um, cefotaxime sodium (Claforan), and 
metronidazole (Flagyl). Beginning on 
postoperative day 12, until the seventh 
postoperative week, selective bacterial 
decontamination that included oral and 
entel'al colistin sulfate (Polymixin E), 
tobramycin sulfate, and amphotericin B 
were given to suppress the growth of 
fungi and potentially pathogenic gram-
negative bacteria while not perturbing 
the growth of anaerobes.' Because the 
donor had positive serological test re-
sults for cytomegalovirus, ganciclovir 
was given for 14 days from the time of 
operation. Acyclovir (acycloguanosine) 
was used after the diagnosis of LPD had 
been established. 10 
Immunosuppression 
Cyclosporine was given intravenous-
ly or enterally to patient 2 to keep the 
blood level at or above 1000 ng/mL by 
radioimmunoassay. \I When LPD was 
diagnosed 91 days after operation, ad-
ministration of cyclosporine was gradu-
ally discontinued and therapy was 
stopped for 15 days. Treatment was 
subsequently reinstituted at low doses. 
The daily dosage of methylpredniso-
lone sodium succinate (Solu-medroD 
was decreased from 100 to 5 mg by day 
9. A I-week course of2.5 mg/d ofOKT36 
was begun on postoperative day 23 be-
cause of the suspicion of rejection. Nine 
doses of25 mg of azathioprine were giv-
en intravenously for a I3-day period be-
ginning on postoperative day 8. As pro-
phylaxis against GVHD, 4.5 Gy of total 
abdominal irradiation from an 8-MV lin-
ear accelerator were given in six divided 
doses from 1 to 3 weeks after trans-
plantation. 
Pharmacokinetic Studies 
Patient 2 was given 50 and 38 mg of 
intravenous cyclosporine for a 2-hour 
period on postoperative days 74 and 
102, respectively. This was followed the 
next day (postoperative days 75 and 
103, respectively) with oral doses of 550 
and 150 mg in olive oil. Multiple blood 
samples were drawn on these study 
dates and analyzed for cyclosporine con-
centration by high-perfonnance liquid 
chromatography. 12 
Assessment of Graft Function 
Liver. - Findings from conventional 
hepatic function tests were obtained al-
most daily and correlated with the re-
sults of tests on liver biopsy samples. 
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Intestine. -Absorption was estimat-
ed from serum glucose levels after Pep-
tamen administration and by cyclospor-
ine blood levels after gastric instillation 
of this drug. The percentage ofnasogas-
tric fluid absorbed was determined by 
measuring stool output. Albumin leak-
age through the intestinal mucosa was 
studied in the fourth postoperative 
month after the intravenous injection of 
human serum albumin labeled with 25 
mCi of chromium 51 and by monitoring 
the amount of isotope that appeared in 
the stool during the next 4 days (normal-
ly < 0.5% for a 3-day period).'3 Stool 
electrolytes, glucose, and protein levels 
were measured. 
Pancreas. - Serial serum trypsin and 
amylase levels were obtained. Serum C 
peptide levels were measured and com-
Fig 4.-Demonstration of OKT3. Left, A small mesenteric donor lymph node is embedded in fat (frozen 
section, pinocyanol. X II 0). Right, Some cells in the nodal sinuses, cortex, and paracortex (arrows) stain 
darkly for the presence of murine IgG (alkaline phosphatase/antialkaline phosphatase, x 110). 
Fig 5. -Computed tomographic scans of initiallym-
phoproliferative disease process. Top, One hun· 
dred nine days after transplantation . Multiple lucen-
cies within the liver parenchyma are seen. 
Histological examination of the cells obtained on 
liver biopsy revealed a polyclonal Iymphoprolifera-
tive disorder (see Fig 6, right). Bottom, One hundred 
thirty-seven days after transplantation. Calcific rims 
surround many of the parenchymallucencies. Histo-
logical examination revealed necrotic Iymphoproli-
ferative cells (see Fig 6, center). 
Fig 6. -Allograft liver, Iymphoproliferative disease. Left, Allograft liver biopsy specimen at 3 months. A diHuse plasmacy-
toid lymphoid proliferation destroys hepatic tissue (Giemsa, x 220). Center, Allograft liver biopsy specimen at 3 'I. 
months. Necrotic Iymphoproliferative disease is represented by ghost cells that have lost both nuclear and cytoplasmic 
staining detail. Occasional nucleated inflammatory cells persist (hematoxylin-eosin, x 240). Right, Hepatic hilar vasculi-
tis present at autopsy. Branches of the hepatic artery, the hilar fibrous tissue, head of pancreas, and adjacent colon are 
permeated by a very polymorphous, anaplastic-looking infiltrate quite diHerent from the earlier Iymphoproliferative 
disorder (hematoxylin-eosin, x 440). 
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Fig 7.-Computed tomographic scan and cholan-
giogram of terminal Iymphoproliferative disease 
process and the hemisected liver at autopsy. Top. 
Computed tomographic scan at 165 days. The he-
patic ducts are obstructed by a large hilar mass 
discovered on histological examination to be mor-
phologically different than the previous Iymphoproli-
ferative disease process (see Fig 6. right). This was 
confirmed by transhepatic cholangiogram (center). 
Note the resolving Iymphoproliferative disease in 
the periphery of the liver on the computed tomo-
graphic scan. Bottom. Transected liver at autopsy 
confirms previously mentioned findings and reveals 
widespread parenchymal necrosis with hemor-
rhage. Note catheters within the hepatic ducts. 
pared with the levels of 0.24 to 0.72 
pmollmL obtained in 20 nonfasting 
diabetics. 
Histocompatibility (HLA) Typing 
With lymphocytotoxicity and two-
color fluorescence testing, patient 2 
showed the following phenotype: 
HLA - A3,30;B35,w42(Bw6);DRw6, -
(DRw52);DQwl,w3. Because the graft 
was flushed with OKT3 monoclonal 
antibody, donor lymphocytes could not 
be readily HLA typed because of high 
background lymphocytotoxicity. How-
ever, AI, A26, and probably Bw4 were 
identified. The recipient had cytotoxic 
antibodies against only 2% of the human 
population. 
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Fig 8. - Parallel graphs of serum total bilirubin levels and cyclosporine (radioimmunoassay IRIA]) levels. Four 
major findings: (1) Rapid fall in total bilirubin level immediately after transplantation. (2) Progressive rise in 
bilirubin level from days 7 to 30. OKT3 administered for one week beginning day 23 with a decline to normal 
after treatment. (3) No rise in bilirubin level is seen during the early Iymphproliferative disease (day 91). 
Cyclosporine was subsequently stopped but restarted due to fear of potential rejection or graft-vs-host 
disease. (4) Late. rapid rise of bilirubin level caused by the obstructing. fatallymphoproliferative disease that 
was only tranSiently relieved by biliary catheter drainage. 
Special Pathological Studies 
In addition to routine histopathologic 
processing, portions of all biopsy sam-
ples were snap frozen to immunostain 
for lymphocyte markers and other stud-
ies. Monoclonal antibodies to HLA-DR, 
CD2, CD3, CD4, CD8, CD20, M02, and 
K and A light chains were used. Poly-
clonal antibodies to IgA, IgG, IgM, ('t-
antichymotrypsin, lysozyme, and S100 
protein were also used. For special typ-
ing studies in tissues, the monoclonal 
antibodies used had specificity against 
HLA-A3 and Bw4; they were detected 
with an alkaline phosphatase/antialka-
line phosphatase reaction. 14 
RESULTS 
Localization of OKT3 From Donor 
Before Treatment 
The donor lymph nodes sampled 1 
hour after the intravenous administra-
tion of 10 mg of OKT3 had a heavy con-
centration of mouse immunoglobulin 
(Fig 4). The murine globulin was not 
sought in extranodal donor tissues. 
Graft-vs-host disease was not ob-
served in specimens of the recipient co-
lon during life or at autopsy, or in the 
skin biopsy sample of a transient rash 3 
weeks after transplantation. At autop-
sy, the depletion of lymphoid tissue 
from the grafted viscera was remark-
able, and, in addition, small nodes from 
the donor mesentery and the host's per-
iaortic region were depleted of lympho-
cytes. The effect, if any, of graft irradia-
tion after transplantation was not 
analyzable. 
Survival and Causes of Death 
Patient 1 died 30 minutes after arrival 
in the intensive care unit. The graft in 
patient 1 had nonspecific findings of ter-
minal shock. At autopsy, the heart had 
biventricular hypertrophy and intersti-
tial myocarditis with focal fibrosis and 
adjacent chronic pericarditis. The lungs 
had massive and multiple pulmonary 
emboli as well as severe congestion with 
focal hemorrhages and necrotizing vas-
culitis. The kidneys had acute bilateral 
tubular necrosis. 
Patient 2 lived for 192 days after 
transplantation; 143 days were spent on 
the ward and 49 days in the pediatric 
intensive care unit. Multifocal LPD was 
diagnosed by computed tomographic 
scan on postoperative day 91 (Figs 5, 
top, and 6, top). One month earlier on 
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January 5, 1988, the Epstein-Barr pro-
file had shown IgG viral capsid antigen 
to be positive at a 1:160 titer, up from 1:5 
on December 24, 1987. The IgM viral 
capsid antigen, IgG (EA, D, R), and 
anti-Epstein-Barr nuclear antigen 
were all less than 1:5 on February 22. 
When a biopsy of the hepatic LPD le-
sions was done at 3 months, the cells 
tested positive for HLA-A3 but not for 
Bw4, consistent with recipient but not 
with donor origin of the lymphoid cells 
in the biopsy specimen. Kupffer's cells 
in adjacent uninvolved liver had the 
same recipient HLA antigens. This was 
not surprising since Kupffer's cells are 
known to be replaced with recipient 
macrophages within 100 days. " The 
plasmacytoid cells in the Iymphoproli-
feration had cytoplasmic immunoglobu-
lin; K and A. chains were equally repre-
sented but virtually all cells had IgG 
heavy chain. These findings were sug-
gestive of polyclonality.3.4 Anti-Ep-
stein-Barr nuclear antigen was detect-
ed in the lymphoid cells and the 
presence of Epstein-Barr virus DNA 
was confirmed using a DN A probe. 
When immunosuppression was stop-
ped on day 104 for 15 days, the lesions 
underwent total necrosis during the 
next 31/2 weeks as proved by biopsy 
specimens. By day 130, there was calci-
fication in the rims of the hepatic masses 
(Figs 5, bottom, and 6, center). Howev-
er, by day 165 a new hilar mass had 
appeared , causing an obstruction of the 
bile duct (Figs 6, right, and 7). The ob-
struction was partly relieved with cath-
eter drainage but sepsis, cardiovascular 
collapse, and multiple system organ fail-
ure eventually followed. 
At autopsy, the liver had multiple ne-
crotic nodules of ''burned out" polymor-
phous LPD with calcific periphel;es. 
The new hilar LPD lesion was morpho-
logically very different from the earlier 
ones. This lesion also involved acontigu-
ous segment of the colon wall and the 
head ofthe pancreas. The cells had large 
bizarre nuclei and surrounded larger 
blood vessels, often infiltrating and de-
stroying the muscular walls of the hilar 
arteries. The cells, unlike those of the 
earlier LPD, were not plasmacytoid. 
Findings of typing for Band T lympho-
cytes and monocyte-dendritic cells were 
negative. There was destructive hilar 
vasculitis with left and right hepatic 
duct infarction and bacterial over-
growth. Hepatic parenchymal infarc-
tion was widespread. Sinusoidal fibrosis 
and ductular proliferation consistent 
with hyperalimentation effect was 
also noted. 
Two small perforations of the intes-
tine found at autopsy were additional 
foci of potentially lethal sepsis; one was 
recent and the other was walled off. 
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Fig 9.-Allograft liver. Left, Biopsy specimen obtained on day 11 after transplantation reveals a cholangitis 
and pericholangitis. Neutrophils are present in and around a bile duct (B). Right, Allograft liver biopsy 
specimen obtained at 6 months. The liver has canalicular cholestasis, bile ductular proliferation, and a 
generalized fine sinusoidal fibrosis (8) believed to be most consistent with prolonged hyperalimentation eHect 
(hematoxylin-eosin, x 200). 
Fig 10.-Barium meal-day 109. Note the feathery normal appearance of the small intestine mucosa. 
Organ Function and Structure 
Liver. - Within 48 hours of trans-
plantation, the bilirubin level fell from 
564.3 to 130 fJ-moVL. After this, there 
was an insidious rise in bilirubin level, 
which did not respond to pulse steroid 
therapy (Fig 8). The I-week course of 
OKT3 beginning on postoperative day 
23 did not influence the bilirubin level, 
but just after this, the levels began to 
fall. A final increase in bilirubin level 
was due to an obstruction of the bile 
duct by the LPD. 
Early transaminase level rises to a 
peak of323 UlL returned to normal by 1 
week. During the time of withdrawal of 
immunosuppression and necrosis of the 
lymphoma, the levels of serum transa-
minases rose during a 10-day period 
from 11/2 to 30 times normal, reaching a 
peak aspartate aminotransferase value 
of 1473 UlL. At the same time, there 
was little effect on the bilirubin level. It 
was thought that the necrosis had oc-
curred very abruptly. 
Normal or near-normal prothrombin 
times suggested intact synthetic func-
tion. Serum albumin concentrations 
were well maintained until a short time 
before death. 
Fifteen sequential liver biopsy speci-
mens were examined. Purulent cholan-
gitis was diagnosed on day 11, with 
gram-negative bacilli identified in the 
tissue. Progressive cholestasis, bile 
ductular proliferation, hepatocyte bal-
looning, and sinusidal fibrosis were be-
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Fig 11. - Gastrointestinal tract. Top left, Colonic biopsy specimen from the donor colon proximal to the 
colostomy, taken 1 week before death (6 months after transplant). The glands eX1end to the muscularis 
mucosae, a normal finding, and there is neither cellular infiltration nor epithelial damage. Lymphoid tissue is 
sparse (hematoxylin-eosin, x 280). Top right, Donor stomach at autopsy. The mucosa has mild atrophy and 
some fibrosis of the lamina propria (hematoxylin-eosin, xI80). Bottom left, Donor ileum at autopsy. In places, 
the villous architecture reveals hyperplasia rather than atrophy. The surface epithelium is intact, the lamina 
propria somewhat fibrotic, but there is no cellular infiltrate (hematoxylin-eosin, x 150) Bottom right, Donor 
pancreas at autopsy. There are foci of cystic ductular proliferation in the head of the pancreas. For the most 
part , islets are abundant (arrows) and there is little atrophy, interstital fibrosis or cellular infiltrate (hematoxylin-
eosin, x 180). 
lieved to be evidence of hyperalimenta-
tion-induced damage (Fig 9). Features 
of rejection were never observed in the 
liver biopsy specimens. The autopsy 
findings reflected damage secondary to 
the LPD. 
The Hollow Viscera.-An upper 
gastrointestinal tract series with a 
small-bowel follow-through was done 
by administering a barium meal on day 
109 (Fig 10). Transit time from stomach 
to colon was 2 liz hours, which is normal 
for a child of this age . The mucosal 
pattern was normal (Fig 10). The muco-
sal barrier was intact. In the fourth 
postoperative month, only 0.46% of the 
intravenous 5lC-labeled albumin was ex-
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creted into the stool over a 4-day period. 
At the end of the second month , only 
5.0±7.0 (SD) giL of total protein, 
33.36 ± 25.37 (SD) fJ..mol/L of glucose, 
and low concentrations of sodium and 
potassium were detected in the stool. 
This suggested that the stool losses 
were mainly water. Two months after 
transplantation, stool volume became 
less and the percent fluid absorption im-
proved from a low of about 10% to a high 
of approximately 75%. The majority of 
stool output was between midnight and 
7 AM . Thtal stool output during periods 
of fasting (156 ± 24 [SD] mL/24 h) was 
similar to that during feeding (159 ± 145 
[SD] mLl24 h). Carbohydrate absorp-
tion was determined to be very effi-
cient, as only small amounts of reducing 
sugars were noted in the stool during 
Peptamen administration. The amount 
of intravenous hyperalimentation was 
greatly reduced and nearly stopped 
when nasogastric feedings were in-
creased with both Peptamen and blen-
derized diets (Fig 3). Positive nitrogen 
balance was present on days 4 to 17. 
Immediately after operation, the pa-
tient weighed 12.6 kg. This increased to 
15.6 kg at the time of nasogastric feed-
ings. Her weight reached a maximum of 
16.3 kg 3 months postoperatively. How-
ever, it dropped to 14.5 to 15.0 kg in the 
last month of life. 
The allografted large bowel was sam-
pled at 6 days, 3 months, and 6 months 
after transplantation. No suggestion of 
rejection was observed (Fig 11, top 
left). The epithelium was intact and 
there was a paucity oflymphoid tissue in 
the 6-month biopsy specimen. 
At autopsy, the allografted gastric 
mucosa was mildly atrophic when com-
pared with the remnant of host stomach 
(Fig 11, top right). The small intestine 
had intermixed wnes of atrophic and 
hypertrophic mucosa. The submucosa 
was mildly fibrotic and the intestinal 
arteries were thick walled. There was 
no evidence of lymphangiectasia (Fig 
11, bottom left). No solitary lymphoid 
follicles were visualized in the large in-
testine. Peyer's patches were not seen 
in the ileum nor were there plasma cells. 
Pancreas. -Serum amylase levels 
were less than 42 U/L throughout the 
entire course. Ten weeks after opera-
tion at a time when the child was not 
being administered exogenous pancre-
atic enzymes, trypsin activity was de-
tected in the colostomy drainage be-
yond a 1:256 dilution (normal for this 
age, > 1:40). The findings were consis-
tent with normal proteolytic activity in 
the feces. 
Serum C peptide level was 0.72 
pmol/mL on day 37. The level was 2.16 
pmol/mL on day 93, three times higher 
than the upper limit of the nonfasting 
diabetic. 
At autopsy, the transplanted pancre-
as was nearly annular and appeared vir-
tually normal except for minor ductoin-
sular proliferation with microcystic 
changes (Fig 11, bottom right). 
Cyclosporine Pharmacokinetics 
The clearance of cyclosporine follow-
ing intravenous administration was 3.4 
mLimin per kllogram during the first 
study period (postoperative days 74 and 
75) and 3.8 mLimin per kllogram during 
the second study period (postoperative 
days 102 and 103). The half-life of cyclo-
sporine was 1l.3 and 16 hours for the 
respective periods. Oral bioavailability 
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Table 2.-Cyclosporine Pharmacokinetics 
Transplant Group 
Pediatric renal 
(n = 7) 
Pedialric liver 
(n=7) 
Mu Itivisceralt 
(n= 1) 
Cyclosporine Clearance Rate, 
mUmln' per Kilogram 
11.8 
(9.8-15.5) 
8.4 
(1 .9-13.9) 
3.4 
3.8 
'Numbers in parentheses indicate range. 
tlV indicates intravenous; and PO. oral. 
was 2% for the first period and 8% for 
the second period. The intestine ab-
sorbed cyclosporine as well as in pediat-
ric patients with liver transplants but 
not as well as in pediatric recipients of 
renal transplants (Table 2). Decreasing 
the volume of olive oil at the time of the 
second testing could have explained the 
improvement of absorption by elimina-
tion of a "castor oil" effect. The lower 
clearance and prolonged half-life of cy-
closporine relative to that in pediatric 
patients with liver and renal trans-
plants may be explained by diminished 
hepatic function during the testing pel;-
ods. The bilirubin level at the time of the 
first study was 102 f.LmoVL, and at the 
time of the second study it was 62.9 
f.LmoVL. 
Evidence of Bacterial Translocation 
During the first 12 postoperative 
days, gram-negative bacteria were cul-
tured from the blood on six occasions. 
After selective decontamination was 
started on day 12 and continued until 
death, the child had no further episodes 
of gram-negative bacteremia. How-
ever, she had 39 blood cultures of gram-
positive organisms, preponderantly 
Staphylococcus epwnnidis. The 
gram-positive infections were treated 
with oral and systemic vancomycin hy-
drochloride, or other antibiotics as dic-
tated by results of cultures. There was 
evidence that the recurrent bacteremia 
originated in the intestine since the 
identical organism was cultured from 
the blood and stool 81 % of the time. The 
patient also had six positive blood cul-
tures of Candida that were treated by 
oral and intravenous amphotericin B. 
On seven occasions despite antibacteri-
al or antifungal therapy, it was neces-
sary to remove the central venous cath-
eter to reverse the septic episode_ 
COMMENT 
The problems of rejection and graft-
vs-host reactions with multi visceral 
transplantation differ only quantita-
tively from those encountered with 
transplantation of the individual or-
gans. The susceptibility to rejection of 
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Volume 
of Distribution, 
Half-life, h Ukg* Bioavailablllty, % 
7.3 4.7 31 
(3-7.4) 
<5-18 
11 .31V 2.3 0 
9.1 PO 2 
16.0 IV 4.3 
13.6 PO 8 
liver and pancreas grafts is common 
knowledge. In addition, complications 
of GVHD after clinical liver transplan-
tation can occurI6•17 and may do so more 
often than is realized_ If the spleen is 
included with whole-pancreas grafts, 
serious or even lethal GVHD can re-
sult. IS-20 Nevertheless, transplantation 
of both the liver and pancreas has been 
carried out with increasing enthusiasm 
and success. 
Comparable progress has not been 
made with the experimental or clinical 
transplantation of the hollow intra-ab-
dominal organs. Before the availability 
of cyclosporine, long-term survival with 
intestinal transplantation was unattain-
able. Afterward, this was accomplished 
in dogs,21.22 pigs, 22 ... and rats. 2S-27 Howev-
er, surgical failures have continued to 
be common and rejection has been diffi-
cult to control. Infection from enteric 
microorganisms leaking through the re-
jecting grafts has been thereby in-
creased. The best results in a large ani-
mal model were reported by Grant et 
al," who were able to consistently ob-
tain protracted survival after orthoto-
pic small-bowel transplantation in out-
bred pigs. Seven of 16 pigs were kept 
alive with carefully monitored intrave-
nous and oral cyclosporine treatment 
for almost 100 days. All therapy was 
then stopped with subsequent long-
term survival as if tolerance had been 
induced. 
Despite these encouraging notations, 
a warning sign was noted in our own 
experience after total pancreas trans-
plantation in which duodenum and je-
junum were included as part of a com-
posite graft. 18 A protein-losing en-
teropathy, hypoproteinemia, and diar-
rhea were caused by the small segment 
of intestine, necessitating resection of 
all of the jejunum and all but a bubble of 
duodenum. The prospect of this com-
plication with a transplant of the en-
tire gastrointestinal tract was what 
prompted our studies on albumin leak-
age in the multivisceral recipient, 
which proved to be negative. 
An even more sinister aspect ofintes-
tinal transplantation has been the 
GVHD that was described long ago both 
in untreated and immunosuppressed 
dogs" '-"" and studied decisively by Mon-
chik and Russell3<l in FI hybrid rats 
whose breeding permitted the lymphoid 
tissue in the intestinal graft to mount an 
attack on the immunologically defense-
less recipient. Strategies to inhibit the 
GVHD have included ex vivo irradia-
tion of the graft. 3().3.I Because GVHD in 
intestinal grafts is proportional to the 
bowel length, 35 the inclusion of an even 
greater mass of lymphoid tissue in a 
multivisceral graft was a cause of 
anxiety. 
In our long-surviving patient, both 
rejection and GVHD were controlled. 
There was no evidence of rejection in 
the biopsy samples of the liver and in-
testinal tract or in the autopsy speci-
mens. Nor was there clinical or his-
topathologic evidence of GVHD. Avoi-
dance of GVHD depends on effective 
immunosuppression, but management 
directed at the lymphoid tissue in the 
multi visceral graft may have contribut-
ed. The tiny donor was given a massive 
dose of OKT3 that had bound to donor 
lymphoid tissues sampled 1 hour later. 
The objective was to prevent or miti-
gate GVHD, something that was fre-
quently reported to be feasible by 
Shaffer et al36 after giving antilympho-
cyte serum to rat donors of intestinal 
grafts in a unidirectional F I hybrid mod-
el. In addition, the graft in our recipient 
was treated prophylactically with 4.5 
Gy in six divided doses during postoper-
ative weeks 1 through 3. 
Therapy to prevent rejection and 
GVHD may have been too intensive. 
Overimmunosuppression is implicit in 
the development of LPD in our patient 
and possibly in the child reported by 
Williams et ai' in this issue of THE JOUR-
NAL. The LPD in our patient's liver bi-
opsy samples contained HLA antigens 
that were recipient specific. There was 
necrosis and calcification of the LPD 
lesions after discontinuance of immuno-
suppression, an effect that has been 
noted before'" and that may have been 
aided by treatment with the antiviral 
agent acyclovir.lo A more ominous-ap-
pearing infiltrate developed in the hilar 
region after restarting cyclosporine and 
prednisone therapy. The decision to re-
sume immunosuppression may have 
been unnecessary since it is conceivable 
that the kind of tolerance induction de-
scribed by Grant et al24 in pigs had al-
ready occurred. 
A tolerant state has been achieved 
often in rodents with a variety of whole-
organ grafts and to a less predictable 
extent in large, outbred animals .37•38 It 
has not been determined if tolerance 
induction will be easier or more difficult 
in intestinal as opposed to other kind of 
grafts or if the presence of functional 
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lymphoid tissue in the graft will simplify 
or complicate the task. Recent studies 
with bone marrow by Knobloch and 
Dennert39 have suggested that the 
immunologically active T lymphocytes 
responsible for GVHD could also be in-
trinsically immunosuppressive and nec-
essary for graft acceptance provided 
they are present in appropriate num-
bers. 
The most encouraging observation in 
our patient was that unequivocal func-
tion was obtained from all of the organs 
in the multi visceral graft. Despite early 
involvement with cholangitis and later 
with LPD and biliary obstruction, the 
liver provided good synthetic and other 
function for more than a half year. The 
hollow gastrointestinal tract viscera al-
lowed near-total enteral nutrition for 
extended periods. Pancreatic function 
was present even though exogenous in-
sulin was intermittently given with 
TPN. None of the organs ever had histo-
pathologic evidence of rejection. 
Much was learned about the manage-
ment of the infectious problems that 
have plagued efforts at transplantation 
of the gastrointestinal tract organs. It 
has been recognized for 30 years that 
bacteria indigenous to the gastrointesti-
nal tract translocated after hepatic 
transplantation when the grafts were 
damaged by ischemia or rejection. 4o .41 
The problem is undoubtedly even more 
critical following preservation and 
transplantation of the small intestine.42 
"Selective decontamination" was at-
tempted in our patient with nonabsorb-
able antibiotics,9 hoping to prevent the 
overgrowth and "leak" of pathogenic 
gram-negative microorganisms and of 
Candida while preserving a normal flo-
ra of intestinal anaerobes. The effort 
was successful in that gram-negative 
bacteria were never again cultured 
from the blood, although Candida was 
not eliminated. Subsequent bacter-
emias were with gram-positive cocci 
predominantly staphylococci, that could 
be controlled with appropriate antibiot-
ics or venous catheter removal. The mi-
croorganisms in the blood usually could 
be predicted 1 or 2 days in advance by 
finding the same bacteria in the stool. 
The most important conclusion from 
our longest surviving patient was that 
she came tantalizingly close to truly 
long-term survival with a functioning 
gastrointestinal tract. There were no 
mortality factors that were beyond ra-
tional explanation nor any management 
adjustments that require therapeutic 
tools that are not now available. It 
seems inevitable that further cautious 
trials of multivisceral and/or intestinal 
transplantation will be made. 
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